MATERIAL AND METHODS
Now a day’s anti-resorptive and anabolic agents are mainly used to treat
osteoporosis. We performed a clinical research investigation and
determine the effectiveness of recombinant PTH i.e. parathyroid hormone
versus bisphosphonates for the treatment of osteoporosis. The study is
aimed to assess the efficacy of recombinant parathyroid hormone versus
bisphosphonates for treating osteoporosis on Visual Analogue Scale
(VAS).